Optical characteristics after Descemet membrane endothelial keratoplasty: 1-year results.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
17
04
2020
accepted:
27
09
2020
entrez:
14
10
2020
pubmed:
15
10
2020
medline:
15
12
2020
Statut:
epublish
Résumé
To evaluate the corneal characteristics after Descemet membrane endothelial keratoplasty (DMEK) compared with normal corneas. Patients who underwent DMEK at Yokohama Minami Kyosai Hospital were included and prospectively evaluated pre-operatively and at postoperative months 1, 3, 6, and 12, and compared to healthy controls. Corneal characteristics evaluated included corneal curvature (keratometric value [KV]; D), central corneal thickness (CCT), peripheral corneal thickness (PCT), and corneal higher-order aberrations [HOAs] at 6.0 mm diameter, calculated by anterior segment optical coherence tomography and logarithm of the minimal angle of resolution [logMAR]. A total of 30 eyes of 30 patients (6 men, 24 women, mean age 73.4 ± 7.4 years) were included and compared with 31 age-matched healthy control eyes (13 men, 18 women; mean age 73.0 ± 6.7 years). LogMAR after DMEK improved from 0.87 ± 0.07 preoperatively to 0.04 ± 0.07 at 12 months postoperatively (p<0.001). Although anterior KVs of DMEK eyes were similar to those of control eyes, posterior KVs were significantly larger (-6.4 ± 0.3 D vs. -6.3 ± 0.2 D; p = 0.02). Total HOAs after DMEK improved from 1.94 ± 1.05 μm preoperatively to 1.05 ± 0.16 μm at 12 months postoperatively (p<0.001), which was significantly higher than that in control eyes (0.63 ± 0.06) (p<0.001). Despite the similar CCTs in the two groups, the PCT was significantly larger in DMEK eyes (704 ± 41 μm vs 669 ± 38 μm, p = 0.002) at 12 months. Despite achieving good visual function and excellent corneal clarity, eyes that underwent DMEK showed a steeper posterior KV and higher corneal HOAs than normal eyes even at 12 months after surgery.
Identifiants
pubmed: 33052928
doi: 10.1371/journal.pone.0240458
pii: PONE-D-20-11108
pmc: PMC7556451
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0240458Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):321-329
pubmed: 30564906
Cornea. 2011 Dec;30(12):1341-5
pubmed: 21955628
Am J Ophthalmol. 2017 Mar;175:148-158
pubmed: 28040524
PLoS One. 2017 Nov 30;12(11):e0188832
pubmed: 29190797
PLoS One. 2016 Aug 18;11(8):e0161075
pubmed: 27536778
Cornea. 2010 Oct;29(10):1086-90
pubmed: 20567202
Cornea. 2006 Sep;25(8):886-9
pubmed: 17102661
Cornea. 2019 May;38(5):535-541
pubmed: 30681522
Cornea. 2015 Nov;34 Suppl 11:S128-35
pubmed: 26448170
Cornea. 2016 Dec;35(12):1562-1568
pubmed: 27362879
Am J Ophthalmol. 2014 Jul;158(1):71-79.e1
pubmed: 24784873
Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2575-84
pubmed: 24008847
J Cataract Refract Surg. 2009 Apr;35(4):688-94
pubmed: 19304090
Cornea. 2006 Sep;25(8):987-90
pubmed: 17102683
Ophthalmology. 2009 Dec;116(12):2361-8
pubmed: 19875170
Ophthalmology. 2017 Apr;124(4):512-518
pubmed: 28094043
Curr Opin Ophthalmol. 2007 Jul;18(4):290-4
pubmed: 17568204
J Refract Surg. 2010 Dec;26(12):972-9
pubmed: 20166622
Cornea. 2019 Aug;38(8):970-975
pubmed: 31135493
Int Ophthalmol Clin. 2000 Winter;40(1):27-43
pubmed: 10713912
Ophthalmology. 2012 Mar;119(3):536-40
pubmed: 22218143
Biomed Res Int. 2017;2017:9720389
pubmed: 28676862
Ophthalmology. 2012 Mar;119(3):528-35
pubmed: 22197439
Cornea. 2016 Jun;35(6):765-71
pubmed: 27032019
Cornea. 2018 Sep;37(9):1185-1188
pubmed: 29634673
Invest Ophthalmol Vis Sci. 2011 Aug 05;52(9):6222-9
pubmed: 21724912
Am J Ophthalmol. 2011 Oct;152(4):537-542.e2
pubmed: 21726845
Ophthalmology. 2019 Jul;126(7):946-957
pubmed: 30776384